Literature DB >> 25409927

SUMO modification of TBK1 at the adaptor-binding C-terminal coiled-coil domain contributes to its antiviral activity.

Vera V Saul1, Rainer Niedenthal2, Andreas Pich3, Friedemann Weber4, M Lienhard Schmitz5.   

Abstract

The non-canonical IKK kinase TBK1 serves as an important signal transmitter of the antiviral interferon response, but is also involved in the regulation of further processes such as autophagy. The activity of TBK1 is regulated by posttranslational modifications comprising phosphorylation and ubiquitination. This study identifies SUMOylation as a novel posttranslational TBK1 modification. TBK1 kinase activity is required to allow the attachment of SUMO1 or SUMO2/3 proteins. Since TBK1 does not bind to the E2 enzyme Ubc9, this modification most likely proceeds via trans-SUMOylation. Mass spectrometry allowed identifying K694 as the SUMO acceptor site, a residue located in the C-terminal coiled-coil domain which is exclusively responsible for the association with the adaptor proteins NAP1, Sintbad and TANK. SUMO modification at K694 contributes to the antiviral function of TBK1 and accordingly the viral protein Gam1 antagonizes this posttranslational modification.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Interferon; NF-κB; Rift Valley fever (RVF) virus; SUMO; TBK1

Mesh:

Substances:

Year:  2014        PMID: 25409927     DOI: 10.1016/j.bbamcr.2014.10.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  18 in total

1.  Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity.

Authors:  Xia Li; Qian Zhang; Yuanyuan Ding; Yiqi Liu; Dezhi Zhao; Kai Zhao; Qicong Shen; Xingguang Liu; Xuhui Zhu; Nan Li; Zhongyi Cheng; Guoping Fan; Qingqing Wang; Xuetao Cao
Journal:  Nat Immunol       Date:  2016-05-30       Impact factor: 25.606

2.  SUMOylation regulates the intracellular fate of ZO-2.

Authors:  Franziska Wetzel; Sonnhild Mittag; Misael Cano-Cortina; Tobias Wagner; Oliver H Krämer; Rainer Niedenthal; Lorenza Gonzalez-Mariscal; Otmar Huber
Journal:  Cell Mol Life Sci       Date:  2016-09-07       Impact factor: 9.261

Review 3.  Emerging role of protein modification in inflammatory bowel disease.

Authors:  Gaoying Wang; Jintao Yuan; Ji Luo; Dickson Kofi Wiredu Ocansey; Xu Zhang; Hui Qian; Wenrong Xu; Fei Mao
Journal:  J Zhejiang Univ Sci B       Date:  2022-03-15       Impact factor: 3.066

Review 4.  Targeting TANK-binding kinase 1 (TBK1) in cancer.

Authors:  Or-Yam Revach; Shuming Liu; Russell W Jenkins
Journal:  Expert Opin Ther Targets       Date:  2020-10-05       Impact factor: 6.902

5.  The CCR4-NOT complex contributes to repression of Major Histocompatibility Complex class II transcription.

Authors:  Alfonso Rodríguez-Gil; Olesja Ritter; Vera V Saul; Jochen Wilhelm; Chen-Yuan Yang; Rudolf Grosschedl; Yumiko Imai; Keiji Kuba; Michael Kracht; M Lienhard Schmitz
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

Review 6.  Regulation of Cellular Antiviral Signaling by Modifications of Ubiquitin and Ubiquitin-like Molecules.

Authors:  Kang Li; Bo Zhong
Journal:  Immune Netw       Date:  2018-02-06       Impact factor: 6.303

7.  THO Complex Subunit 7 Homolog Negatively Regulates Cellular Antiviral Response against RNA Viruses by Targeting TBK1.

Authors:  Tian-Sheng He; Tao Xie; Jing Li; Ya-Xian Yang; Changsheng Li; Weiying Wang; Lingzhen Cao; Hua Rao; Cynthia Ju; Liang-Guo Xu
Journal:  Viruses       Date:  2019-02-15       Impact factor: 5.048

8.  Selective autophagy controls the stability of TBK1 via NEDD4 to balance host defense.

Authors:  Weihong Xie; Shouheng Jin; Chenqiu Zhang; Shuai Yang; Yaoxing Wu; Yong Zhao; Zhou Songyang; Jun Cui
Journal:  Cell Death Differ       Date:  2021-07-13       Impact factor: 15.828

Review 9.  Protein SUMOylation modification and its associations with disease.

Authors:  Yanfang Yang; Yu He; Xixi Wang; Ziwei Liang; Gu He; Peng Zhang; Hongxia Zhu; Ningzhi Xu; Shufang Liang
Journal:  Open Biol       Date:  2017-10       Impact factor: 6.411

Review 10.  Roles for the IKK-Related Kinases TBK1 and IKKε in Cancer.

Authors:  Joel K Durand; Qing Zhang; Albert S Baldwin
Journal:  Cells       Date:  2018-09-15       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.